Home LiteratureArticle Details
PMID: 17058200 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Lung cancer risk prediction: a tool for early detection.

International journal of cancer ·Vol. 120 ·No. 1 ·2007-01-01 ·Pages 1-6

Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK

Abstract

Although 45% of men and 39% of women will be diagnosed with cancer in their lifetime, it is difficult to predict which individuals will be affected. For some cancers, substantial progress in individual risk estimation has already been made. However, relatively few models have been developed to predict lung cancer risk beyond effects of age and smoking. This paper reviews published models for lung cancer risk prediction, discusses their potential contribution to clinical and research settings and suggests improvements to the risk modeling strategy for lung cancer. The sensitivity and specificity of existing cancer risk models is less than optimal. Improvement in individual risk prediction is important for selection of individuals for prevention or early detection interventions. In addition to smoking, factors related to occupational exposure, personal medical history and family history of cancer can add to the predictive power. A good risk prediction model is one that can identify a small fraction of the population in which a large proportion of the disease cases will occur. In the future, genetic and other biological markers are likely to be useful, although they will require rigorous evaluation. Validation is essential to establish the predictive effect and for ongoing monitoring of the model's continued relevance.

MeSH Terms
Early Diagnosis Humans Lung Neoplasms/diagnosis,epidemiology Risk Assessment Risk Factors
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Cassidy Adrian
Roy Castle Lung Cancer Research Programme, University of Liverpool Cancer Research Centre, Liverpool, United Kingdom.
Duffy Stephen W
Myles Jonathan P
Liloglou Triantafillos
Field John K
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
2007-01-01
Pages
1-6
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Grants
Medical Research Council · G9900432 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com